【作者(必填)】 Wang C[size=0.8461em]1, Zheng H[size=0.8461em]1, He JW[size=0.8461em]1, Zhang H[size=0.8461em]1,
【文题(必填)】 Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.【年份(必填)】
[size=0.8465em]Pharmacogenomics J.[size=0.8465em] [size=0.8465em]2014 Sep 16.
【全文链接或数据库名称(选填)】[size=0.8465em] http://www.ncbi.nlm.nih.gov/pubmed/25223561